Bernay, France

Molly Cannet

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sk Global Chemical Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Molly Cannet. Retrieved from https://idiyas.com/inventor/molly-cannet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Molly Cannet: Innovator at Arkema France

Introduction

Molly Cannet is an accomplished inventor based in Chateaudun, France. She is currently associated with Arkema France, a leading specialty chemicals company. Despite having no patents to her name, her contributions to the field of innovation are noteworthy.

Latest Patents

Molly Cannet has not yet registered any patents. However, her work at Arkema France indicates her involvement in significant research and development projects.

Career Highlights

Throughout her career, Molly has demonstrated a strong commitment to advancing technology and innovation. Her role at Arkema France allows her to collaborate with talented professionals in the industry, enhancing her skills and expertise.

Collaborations

Molly works alongside esteemed colleagues such as Guillaume Jacques and Stéphane Bizet. Their teamwork fosters a creative environment that encourages innovative solutions.

Conclusion

Molly Cannet is a promising inventor whose work at Arkema France highlights her potential in the field of innovation. Her journey in the industry is just beginning, and her future contributions may lead to significant advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…